Literature DB >> 27252379

Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.

Sofia Mortensen1, Jan K Jensen1, Gregers R Andersen2.   

Abstract

The lectin (LP) and classical (CP) pathways are two of the three main activation cascades of the complement system. These pathways start with recognition of different pathogen- or danger-associated molecular patterns and include identical steps of proteolytic activation of complement component C4, formation of the C3 proconvertase C4b2, followed by cleavage of complement component C2 within C4b2 resulting in the C3 convertase C4b2a. Here, we describe the solution structures of the two central complexes of the pathways, C3 proconvertase and C3 convertase, as well as the unbound zymogen C2 obtained by small angle x-ray scattering analysis. We analyzed both native and enzymatically deglycosylated C4b2 and C2 and showed that the resulting structural models were independent of the glycans. The small angle x-ray scattering-derived models suggest a different activation mode for the CP/LP C3 proconvertase as compared with that established for the alternative pathway proconvertase C3bB. This is likely due to the rather different structural and functional properties of the proteases activating the proconvertases. The solution structure of a stabilized form of the active CP/LP C3 convertase C4b2a is strikingly similar to the crystal structure of the alternative pathway C3 convertase C3bBb, which is in accordance with their identical functions in cleaving the complement proteins C3 and C5.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  complement system; convertase; innate immunity; protease; small angle x-ray scattering (SAXS); structural biology

Mesh:

Substances:

Year:  2016        PMID: 27252379      PMCID: PMC4974366          DOI: 10.1074/jbc.M116.722017

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

2.  Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.

Authors:  Sofia Mortensen; Rune T Kidmose; Steen V Petersen; Ágnes Szilágyi; Zoltan Prohászka; Gregers R Andersen
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

3.  Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2.

Authors:  T Vorup-Jensen; S V Petersen; A G Hansen; K Poulsen; W Schwaeble; R B Sim; K B Reid; S J Davis; S Thiel; J C Jensenius
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

4.  Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).

Authors:  Claire L Harris; Rachel J M Abbott; Richard A Smith; B Paul Morgan; Susan M Lea
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

5.  The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).

Authors:  Fredrik Bexborn; Per Ola Andersson; Hui Chen; Bo Nilsson; Kristina N Ekdahl
Journal:  Mol Immunol       Date:  2007-12-21       Impact factor: 4.407

6.  C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.

Authors:  Z Fishelson; H J Müller-Eberhard
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.

Authors:  John Bernet; Jayati Mullick; Yogesh Panse; Pradeep B Parab; Arvind Sahu
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.

Authors:  Lubka T Roumenina; Mathieu Jablonski; Christophe Hue; Jacques Blouin; Jordan D Dimitrov; Marie-Agnes Dragon-Durey; Mathieu Cayla; Wolf H Fridman; Marie-Alice Macher; David Ribes; Luc Moulonguet; Lionel Rostaing; Simon C Satchell; Peter W Mathieson; Catherine Sautes-Fridman; Chantal Loirat; Catherine H Regnier; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113

9.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

10.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  9 in total

1.  Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.

Authors:  Simon A Mortensen; Bjoern Sander; Rasmus K Jensen; Jan Skov Pedersen; Monika M Golas; Jens C Jensenius; Annette G Hansen; Steffen Thiel; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-19       Impact factor: 11.205

Review 2.  Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.

Authors:  Dani A C Heesterbeek; Mathieu L Angelier; Richard A Harrison; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2018-08-27       Impact factor: 7.349

3.  Purification of Human Complement Component C4 and Sample Preparation for Structural Biology Applications.

Authors:  Alessandra Zarantonello; Sofia Mortensen; Nick S Laursen; Gregers R Andersen
Journal:  Methods Mol Biol       Date:  2021

4.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

Review 5.  Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies.

Authors:  Alessandra Zarantonello; Henrik Pedersen; Nick S Laursen; Gregers R Andersen
Journal:  Biomolecules       Date:  2021-02-17

6.  Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.

Authors:  Nisha Asok Kumar; Sreenath Muraleedharan Suma; Umerali Kunnakkadan; Joydeep Nag; Reshma Koolaparambil Mukesh; Douglas S Lyles; John Bernet Johnson
Journal:  Viruses       Date:  2021-02-26       Impact factor: 5.048

7.  A novel biomimetic nanomedicine system with anti-inflammatory and anti-osteoporosis effects improves the therapy efficacy of steroid-resistant nephrotic syndrome.

Authors:  Jian Li; Mingyi Zhao; Xinying Xiang; Qingnan He; Rong Gui
Journal:  J Nanobiotechnology       Date:  2021-12-13       Impact factor: 10.435

8.  A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.

Authors:  Regina Michelis; Tamar Tadmor; Masad Barhoum; Mona Shehadeh; Lev Shvidel; Ariel Aviv; Galia Stemer; Najib Dally; Naomi Rahimi-Levene; Mona Yuklea; Andrei Braester
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

Review 9.  Complement C4, Infections, and Autoimmune Diseases.

Authors:  Hongbin Wang; Mengyao Liu
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.